These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 16868443)

  • 1. HLA-dependent hypersensitivity to nevirapine in Sardinian HIV patients.
    Littera R; Carcassi C; Masala A; Piano P; Serra P; Ortu F; Corso N; Casula B; La Nasa G; Contu L; Manconi PE
    AIDS; 2006 Aug; 20(12):1621-6. PubMed ID: 16868443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of nevirapine hypersensitivity and its effect on the association between hepatitis C status and mortality in antiretroviral drug-naive HIV-positive patients.
    Phillips E; Gutiérrez S; Jahnke N; Yip B; Lima VD; Hogg RS; Harrigan PR; Montaner JS
    AIDS; 2007 Jul; 21(12):1561-8. PubMed ID: 17630551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-Cw8 primarily associated with hypersensitivity to nevirapine.
    Gatanaga H; Yazaki H; Tanuma J; Honda M; Genka I; Teruya K; Tachikawa N; Kikuchi Y; Oka S
    AIDS; 2007 Jan; 21(2):264-5. PubMed ID: 17197830
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.
    Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Chantratita W; Nakamura Y
    Pharmacogenet Genomics; 2009 Feb; 19(2):139-46. PubMed ID: 19104471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.
    Mallal S; Nolan D; Witt C; Masel G; Martin AM; Moore C; Sayer D; Castley A; Mamotte C; Maxwell D; James I; Christiansen FT
    Lancet; 2002 Mar; 359(9308):727-32. PubMed ID: 11888582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity.
    Keane NM; Pavlos RK; McKinnon E; Lucas A; Rive C; Blyth CC; Dunn D; Lucas M; Mallal S; Phillips E
    AIDS; 2014 Aug; 28(13):1891-901. PubMed ID: 24911354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Third-trimester maternal toxicity with nevirapine use in pregnancy.
    Joy S; Poi M; Hughes L; Brady MT; Koletar SL; Para MF; Fan-Havard P
    Obstet Gynecol; 2005 Nov; 106(5 Pt 1):1032-8. PubMed ID: 16260522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
    Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
    Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-dependent hypersensitivity reaction to nevirapine in Chinese Han HIV-infected patients.
    Gao S; Gui XE; Liang K; Liu Z; Hu J; Dong B
    AIDS Res Hum Retroviruses; 2012 Jun; 28(6):540-3. PubMed ID: 21902584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses to abacavir in antigen-presenting cells from hypersensitive patients.
    Martin AM; Almeida CA; Cameron P; Purcell AW; Nolan D; James I; McCluskey J; Phillips E; Landay A; Mallal S
    AIDS; 2007 Jun; 21(10):1233-44. PubMed ID: 17545699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The frequency, activation, and coreceptor expression of lymphocytes in human immunodeficiency virus/hepatitis C virus co-infected patients in China.
    Shi W; Zhang Z; Zhang M; Liu J; Jiang Y; Wang Y; Jin X; Han X; Shang H
    Jpn J Infect Dis; 2009 Jul; 62(4):284-8. PubMed ID: 19628906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haplotype analysis of HLA-A, -B antigens and -DRB1 alleles in south Indian HIV-1-infected patients with and without pulmonary tuberculosis.
    Raghavan S; Selvaraj P; Swaminathan S; Alagarasu K; Narendran G; Narayanan PR
    Int J Immunogenet; 2009 Jun; 36(3):129-33. PubMed ID: 19392836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients.
    Rey D; Hoen B; Chavanet P; Schmitt MP; Hoizey G; Meyer P; Peytavin G; Spire B; Allavena C; Diemer M; May T; Schmit JL; Duong M; Calvez V; Lang JM
    J Antimicrob Chemother; 2009 Feb; 63(2):380-8. PubMed ID: 19036752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between HLA antigens and the HIV infection in patients from the state of Zulia].
    Hassanhi MS; Rivera SE; Fuenmayor AM; Márquez GC; Salas D; de Avila LM; Sanabria A; de Ruiz Z
    Sangre (Barc); 1995 Apr; 40(2):109-13. PubMed ID: 7784939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HLA-B*5701 and abacavir hypersensitivity reaction].
    Servonnet A; Leclercq E; Delacour H; Ceppa F
    Pathol Biol (Paris); 2010 Dec; 58(6):e95-100. PubMed ID: 19243901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation, in previously treated HIV-1 positive patients, between hypersensitivity reaction to abacavir and the presence of the HLA-B*5701 allele].
    Pérez Prior N; Rocher Milla A; Soler Company E; Flores Cid J; Sarria Chust B
    Farm Hosp; 2009; 33(3):155-60. PubMed ID: 19712599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.
    Giorgini S; Martinelli C; Tognetti L; Carocci A; Giuntini R; Mastronardi V; Torricelli F; Leoncini F; Lotti T
    Dermatol Ther; 2011; 24(6):591-4. PubMed ID: 22515676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-B*5701 screening for hypersensitivity to abacavir.
    Mallal S; Phillips E; Carosi G; Molina JM; Workman C; Tomazic J; Jägel-Guedes E; Rugina S; Kozyrev O; Cid JF; Hay P; Nolan D; Hughes S; Hughes A; Ryan S; Fitch N; Thorborn D; Benbow A;
    N Engl J Med; 2008 Feb; 358(6):568-79. PubMed ID: 18256392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.